製品の概要

  • 製品名
    Anti-SQSTM1 / p62 antibody
    SQSTM1 / p62 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to SQSTM1 / p62
  • アプリケーション
    適用あり: WB, ELISA, IHC-P, ICC/IF, IHC-FoFrmore details
  • 種交差性
    交差種: Mouse, Rat, Human
  • 免疫原

    A 14 amino acid peptide from near the Carboxy terminus of Human SQSTM1/ p62 (GenBank accession no. Q13501).

  • ポジティブ・コントロール
    • WB: Mouse gastrocnemius lysate; Human spleen tissue lysate. IHC: Mouse VCPR155H/R155H quadricep tissue. IHC-P: Human spleen tissue. ICC/IF: HeLa cells; Murine embryonic fibroblast; Rat spleen cells.

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab91526 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 47 kDa.
ELISA Use at an assay dependent concentration.
IHC-P Use at an assay dependent concentration.
ICC/IF Use at an assay dependent concentration. PubMed: 21757726
IHC-FoFr Use at an assay dependent concentration. PubMed: 22898872

ターゲット情報

  • 機能
    Adapter protein which binds ubiquitin and may regulate the activation of NFKB1 by TNF-alpha, nerve growth factor (NGF) and interleukin-1. May play a role in titin/TTN downstream signaling in muscle cells. May regulate signaling cascades through ubiquitination. Adapter that mediates the interaction between TRAF6 and CYLD (By similarity). May be involved in cell differentiation, apoptosis, immune response and regulation of K(+) channels.
  • 組織特異性
    Ubiquitously expressed.
  • 関連疾患
    Defects in SQSTM1 are a cause of Paget disease of bone (PDB) [MIM:602080]. PDB is a metabolic bone disease affecting the axial skeleton and characterized by focal areas of increased and disorganized bone turn-over due to activated osteoclasts. Manifestations of the disease include bone pain, deformity, pathological fractures, deafness, neurological complications and increased risk of osteosarcoma. PDB is a chronic disease affecting 2 to 3% of the population above the age of 40 years.
  • 配列類似性
    Contains 1 OPR domain.
    Contains 1 UBA domain.
    Contains 1 ZZ-type zinc finger.
  • ドメイン
    The UBA domain binds specifically 'Lys-63'-linked polyubiquitin chains of polyubiquitinated substrates. Mediates the interaction with TRIM55.
    The OPR domain mediates homooligomerization and interactions with PRKCZ, PRKCI, MAP2K5 and NBR1.
    The ZZ-type zinc finger mediates the interaction with RIPK1.
  • 翻訳後修飾
    Phosphorylated. May be phosphorylated by PRKCZ (By similarity). Phosphorylated in vitro by TTN.
  • 細胞内局在
    Cytoplasm. Late endosome. Nucleus. Sarcomere (By similarity). In cardiac muscles localizes to the sarcomeric band (By similarity). Localizes to late endosomes. May also localize to the nucleus. Accumulates in neurofibrillary tangles and in Lewy bodies of neurons from individuals with Alzheimer and Parkinson disease respectively. Enriched in Rosenthal fibers of pilocytic astrocytoma. In liver cells, accumulates in Mallory bodies associated with alcoholic hepatitis, Wilson disease, indian childhood cirrhosis and in hyaline bodies associated with hepatocellular carcinoma.
  • Information by UniProt
  • 参照データベース
  • 別名
    • A170 antibody
    • DMRV antibody
    • EBI 3 associated protein of 60 kDa antibody
    • EBI 3 associated protein p60 antibody
    • EBI3 associated protein of 60 kDa antibody
    • EBI3 associated protein p60 antibody
    • EBI3-associated protein of 60 kDa antibody
    • EBIAP antibody
    • FTDALS3 antibody
    • MGC127197 antibody
    • ORCA antibody
    • OSF-6 antibody
    • Osi antibody
    • OSIL antibody
    • Oxidative stress induced like antibody
    • p60 antibody
    • p62 antibody
    • p62B antibody
    • Paget disease of bone 3 antibody
    • PDB 3 antibody
    • PDB3 antibody
    • Phosphotyrosine independent ligand for the Lck SH2 domain of 62 kDa antibody
    • Phosphotyrosine independent ligand for the Lck SH2 domain p62 antibody
    • Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa antibody
    • PKC-zeta-interacting protein antibody
    • Protein kinase C-zeta-interacting protein antibody
    • Sequestosome 1 antibody
    • Sequestosome-1 antibody
    • SQSTM 1 antibody
    • SQSTM_HUMAN antibody
    • Sqstm1 antibody
    • STAP antibody
    • STONE14 antibody
    • Ubiquitin binding protein p62 antibody
    • Ubiquitin-binding protein p62 antibody
    • ZIP 3 antibody
    • ZIP antibody
    • ZIP3 antibody
    see all

画像

  • All lanes : Anti-SQSTM1 / p62 antibody (ab91526) at 1/1000 dilution

    Lane 1 : Mouse gastrocnemius
    Lane 2 : Mouse gastrocnemius
    Lane 3 : Mouse gastrocnemius

    Lysates/proteins at 40 µg per lane.

    Secondary
    Anti-Rabbit IgG (H + L) at 1/10000 dilution

    Predicted band size : 47 kDa

    This image is courtesy of an anonymous Abreview

    See Abreview

  • Immunohistochemical analysis of mouse VCPR155H/R155H quadricep tissue, staining SQSTM1 / p62 (green) with ab91526.

    Mice were transcardially perfused with 4% paraformaldehyde before muscle tissue was frozen and sectioned. Tissue was incubated with primary antibody before detection with a fluorescein-conjugated anti-rabbit secondary antibody. Nuclei were stained with DAPI (blue).
  • Paraffin-embedded human spleen tissue stained for SQSTM1/p62 using ab91526 at 5 µg/ml in immunohistochemical analysis.

  • Lane 1 : Anti-SQSTM1 / p62 antibody (ab91526) at 1 µg/ml
    Lane 2 : Anti-SQSTM1 / p62 antibody (ab91526) at 2 µg/ml

    Lane 1 : Human spleen tissue lysate
    Lane 2 : Human spleen tissue lysate

    Lysates/proteins at 15 µg per lane.


    Predicted band size : 47 kDa
  • ab91526 at a 1/500 dilution staining SQSTM1/ p62 in wild type murine embryonic fibroblasts by Immunocytochemistry/ Immunofluorescence.
  • Immunofluorescence of SQSTM1 in Rat Spleen cells using ab91526 at 20 ug/ml.

参考文献

This product has been referenced in:
  • Patschan D  et al. Endothelial Colony Forming Cells (ECFCs) in murine AKI - implications for future cell-based therapies. BMC Nephrol 18:53 (2017). IHC-P ; Mouse . Read more (PubMed: 28166726) »
  • Cho JH  et al. Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia. PLoS Genet 13:e1006819 (2017). WB . Read more (PubMed: 28558013) »

See all 48 Publications for this product

レビューと Q&A

Filter by Application

Filter by Species

Filter by Ratings

Application
Immunocytochemistry/ Immunofluorescence
Sample
African green monkey Cell (Kidney)
Permeabilization
Yes - 0.2% Triron X100
Specification
Kidney
Blocking step
Serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 37°C
Fixative
Methanol
Username

Abcam user community

Verified customer

投稿 Sep 27 2017

Application
Western blot
Sample
Mouse Cell lysate - whole cell (Gastrocnemius)
Gel Running Conditions
Reduced Denaturing (12)
Loading amount
40 µg
Specification
Gastrocnemius
Blocking step
Odyssey Blocking Buffer as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 100% · Temperature: 26°C
Username

Abcam user community

Verified customer

投稿 Apr 20 2015

Application
Western blot
Loading amount
40 µg
Gel Running Conditions
Reduced Denaturing (12)
Sample
Human Cell lysate - whole cell (COV434 cell line)
Specification
COV434 cell line
Blocking step
Odyssey Blocking Buffer as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 100% · Temperature: 26°C
Username

Abcam user community

Verified customer

投稿 Feb 13 2015

Application
Western blot
Loading amount
15 µg
Gel Running Conditions
Reduced Denaturing (4-20%)
Sample
Mouse Tissue lysate - whole (Lung)
Specification
Lung
Treatment
Bafilomycin
Blocking step
Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 4°C
Username

Mr. Alan Chang

Verified customer

投稿 Mar 20 2014

Abcam guarantees this product to work in the species/application used in this Abreview.
Application
Western blot
Sample
Mouse Tissue lysate - whole (Heart)
Loading amount
40 µg
Specification
Heart
Gel Running Conditions
Reduced Denaturing (10)
Blocking step
Milk as blocking agent for 2 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 30°C
Username

Mr. Mtuhtu S.Gounder

Verified customer

投稿 Dec 02 2011

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録